Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PurMed Global CBD Oil Tincture is a physician-grade botanical product containing cannabidiol (CBD) extracted from the hemp plant. It is formulated in a medium-chain triglyceride (MCT) oil base for sublingual or oral administration. As a non-intoxicating phytocannabinoid, CBD interacts with the endocannabinoid system and various other receptor pathways, including serotonin and vanilloid receptors, to provide symptomatic relief for pain, inflammation, anxiety, and sleep disturbances. The product is marketed for general wellness and is produced through a controlled "Seed-to-Sale" supply chain to ensure purity and the absence of THC.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PurMed Global CBD Oil Tincture.